Skip to main content
Login
Contact
Subscribe
Search form
Search
The Decatur Daily Democrat
Home
Forms
Delivery Concerns
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Photos
Videos
Games
Entertainment
Local Guide
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Xeris Pharmaceuticals Inc
(NQ:
XERS
)
4.230
USD
-0.030 (-0.70%)
Official Closing Price
Updated: 7:57 PM EDT, Apr 9, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Xeris Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
April 01, 2021
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug...
From
Business Wire News Releases
Xeris Pharmaceuticals Becomes Oversold (XERS)
March 24, 2021
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Tags
Stocks
From
Market News Video
NASDAQ:XERS Shareholder Notice: Investigation over Possible Securities Laws Violations by Xeris Pharmaceuticals, Inc.
March 22, 2021
San Diego, CA -- (SBWIRE) -- 03/22/2021 -- Xeris Pharmaceuticals, Inc. is under investigation concerning potential violations of securities laws in connection with certain financial statements.
From
SBWire - Latest Press Releases
Interesting XERS Call Options For May 21st
March 19, 2021
Investors in Xeris Pharmaceuticals Inc (XERS) saw new options become available this week, for the May 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the XERS...
Tags
Stocks
From
Market News Video
3 Penny Stocks To Watch Today After Big News This Week
March 16, 2021
Tags
Market News
From
Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Iterum Therapeutics Appoints Beth P. Hecht to Board of Directors
March 16, 2021
From
GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Xeris Pharmaceuticals, Inc. - XERS
March 12, 2021
Pomerantz LLP is investigating claims on behalf of investors of Xeris Pharmaceuticals, Inc. ("Xeris" or the "Company") (NASDAQ: XERS). Such investors are advised to contact Robert S. Willoughby at...
From
PR Newswire
Xeris Pharmaceuticals Announces Pricing of $27.0 Million Registered Direct Offering
March 11, 2021
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible...
From
Business Wire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Xeris Pharmaceuticals, Inc. - XERS
March 10, 2021
Pomerantz LLP is investigating claims on behalf of investors of Xeris Pharmaceuticals, Inc. ("Xeris" or the "Company") (NASDAQ: XERS). Such investors are advised to contact Robert S. Willoughby at...
From
PR Newswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 09, 2021
Gainers INVO Bioscience (NASDAQ:INVO) shares increased by 183.59% to $8.82 during Tuesday's regular session. INVO ...
Tags
SLS
EARS
ANPC
From
Benzinga
61 Stocks Moving In Tuesday's Mid-Day Session
March 09, 2021
Gainers INVO Bioscience, Inc. (NASDAQ: INVO) shares jumped 230.6% to $10.28 after the company announced an amendment under its ...
Tags
EYES
DISCA
MTLS
From
Benzinga
Why Xeris Pharmaceuticals Is Trading Lower Today
March 09, 2021
Xeris Pharmaceuticals's Stock Price And Volume Action Xeris Pharmaceuticals's (NASDAQ:XERS) stock has been falling Tuesday, ...
Tags
Trading Ideas
BZI/WIIM
Market News
From
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 09, 2021
Gainers AnPac Bio-Medical Science (NASDAQ:ANPC) shares increased by 72.24% to $9.99 during Tuesday's pre-market ...
Tags
SURF
Markets
INVO
From
Benzinga
The Daily Biotech Pulse: Regulatory Setback For Acadia, Lilly Forges Diabetes Antibody Treatment Collaboration, Aytu's Positive COVID-19 Data
March 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
Penny Stocks
NARI
XERS
From
Benzinga
Xeris Pharmaceuticals Reports Fourth Quarter and Full-year 2020 Financial Results and Recent Highlights
March 09, 2021
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible...
From
Business Wire News Releases
Earnings Scheduled For March 9, 2021
March 09, 2021
Companies Reporting Before The Bell • Barnes & Noble Education (NYSE:BNED) is expected to report quarterly loss at ...
Tags
CREX
Earnings Scheduled
BZI/UE
From
Benzinga
Earnings Outlook for Xeris Pharmaceuticals
March 08, 2021
Xeris Pharmaceuticals (NASDAQ:XERS) unveils its next round of earnings this Tuesday, March 09. Get prepared with Benzinga's ultimate ...
Tags
Market News
XERS
Benzinga
From
Benzinga
The Week Ahead In Biotech (March 7-13): Conference Presentations And More Earnings
March 06, 2021
Biotech stocks continued to move southward in the week ended March 5, as the broader market extended its sell-off. Though light on news, ...
Tags
DRIO
BDSI
HARP
From
Benzinga
Xeris Pharmaceuticals Breaks Below 200-Day Moving Average - Notable for XERS
March 04, 2021
In trading on Thursday, shares of Xeris Pharmaceuticals Inc (XERS) crossed below their 200 day moving average of $4.80, changing hands as low as $4.68 per share. Xeris Pharmaceuticals Inc shares are...
Tags
Stocks
From
Market News Video
Xeris Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call and Webcast on March 9, 2021
March 02, 2021
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible...
From
Business Wire News Releases
Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates
February 28, 2021
Most Food and Drug Administration decisions scheduled for February were positive, and more importantly five new molecular entities ...
Tags
BMY
AVEO
Biotech
From
Benzinga
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
February 26, 2021
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug...
From
Business Wire News Releases
Xeris Pharmaceuticals to Webcast Upcoming Investor Conference Presentations
February 18, 2021
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug...
From
Business Wire News Releases
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 12, 2021
Gainers Artelo Biosciences (NASDAQ:ARTL) shares rose 61.34% to $2.63 during Friday's pre-market session. The company's market cap ...
Tags
ARTL
Health Care
Trading Ideas
From
Benzinga
Thinking about buying stock in Artelo Biosciences, Xeris Pharmaceuticals, Inovio Pharmaceuticals, Novan, or Fisker?
February 12, 2021
InvestorsObserver issues critical PriceWatch Alerts for ARTL, XERS, INO, NOVN, and FSR.
From
PR Newswire
The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed
February 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
VLON
MEDP
AYTU
From
Benzinga
Xeris Pharma's Hypoglycemia Med Receives European Nod, Shares Spike
February 12, 2021
TheEuropean Commission has approvedXeris Pharmaceuticals Inc's(NASDAQ:XERS) Ogluo (glucagon) injection to ...
Tags
News
General
hypoglycemia
From
Benzinga
Xeris Pharmaceuticals Receives European Commission Approval of Ogluo™ (glucagon) Injection for the Treatment of Severe Hypoglycaemia in Adults, Adolescents, and Children Aged 2 Years and Over With Dia
February 12, 2021
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible...
From
Business Wire News Releases
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement
February 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
COLL
BEAM
SESN
From
Benzinga
Stocks That Hit 52-Week Highs On Monday
February 08, 2021
Monday morning saw 558 companies set new 52-week highs. Noteables: The largest company on a market cap ...
Tags
Intraday Update
Trading Ideas
WBAI
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.